{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:27:03Z","timestamp":1772641623699,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.anai.2018.05.014","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:38:47Z","timestamp":1527169127000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-5435","authenticated-orcid":false,"given":"Nives","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Wikenheiser-Brokamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2018.05.014_bib0001","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-0032-1325164","article-title":"Update on eosinophilic lung diseases","volume":"33","author":"Bhatt","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2500\/aap.2013.34.3628","article-title":"Primary eosinophilic lung diseases","volume":"34","author":"Rose","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2018.05.014_bib0003","first-page":"537","article-title":"Pulmonary eosinophilic infiltrates","volume":"102","author":"Rossi","year":"2010","journal-title":"Pathologica"},{"key":"10.1016\/j.anai.2018.05.014_bib0004","series-title":"Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease","author":"Katzenstein","year":"2006"},{"key":"10.1016\/j.anai.2018.05.014_bib0005","series-title":"Non-neoplastic Disorders of the Lower Respiratory Tract","author":"Travis","year":"2002"},{"key":"10.1016\/j.anai.2018.05.014_bib0006","doi-asserted-by":"crossref","unstructured":"Suzuki Y, Suda T. Long-term management and persistent impairment of pulmonary function in chronic eosinophilic pneumonia: a review of the previous literature [published online January 23, 2018]. Allergol Int. doi: 10.1016\/j.alit.2017.12.004.","DOI":"10.1016\/j.alit.2017.12.004"},{"key":"10.1016\/j.anai.2018.05.014_bib0007","first-page":"98","article-title":"A case of cocaine-induced eosinophilic pneumonia: case report and review of the literature","volume":"23","author":"Reyes","year":"2018","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.anai.2018.05.014_bib0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-2006-939517","article-title":"Acute eosinophilic pneumonia","volume":"27","author":"Allen","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0009","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.anai.2018.05.014_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management","volume":"26","author":"Mahr","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.anai.2018.05.014_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/BOR.0b013e328333390b","article-title":"Churg-Strauss syndrome: evidence for disease subtypes?","volume":"22","author":"Pagnoux","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.anai.2018.05.014_bib0012","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1586\/1744666X.2016.1142874","article-title":"The spectrum of allergic fungal diseases of the upper and lower airways","volume":"12","author":"Rodrigues","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","article-title":"Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome","volume":"127","author":"Lotvall","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fmed.2017.00158","article-title":"Asthma endotypes and an overview of targeted therapy for asthma","volume":"4","author":"Svenningsen","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.anai.2018.05.014_bib0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","article-title":"Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome","volume":"67","author":"Khoury","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2018.05.014_bib0016","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1182\/blood-2009-07-143552","article-title":"How I treat hypereosinophilic syndromes","volume":"114","author":"Klion","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.anai.2018.05.014_bib0017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/ehm.11.81","article-title":"Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field","volume":"5","author":"Valent","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.anai.2018.05.014_bib0018","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0019","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0021","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2010-05-286757","article-title":"Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease","volume":"117","author":"Elling","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.anai.2018.05.014_bib0022","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.anai.2018.05.014_bib0023","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.anai.2018.05.014_bib0024","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anai.2018.05.014_bib0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaip.2016.03.020","article-title":"Hypereosinophilia in Children and Adults: A Retrospective Comparison","volume":"4","author":"Williams","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2018.05.014_bib0026","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2016.75","article-title":"Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anai.2018.05.014_bib0027","article-title":"Idiopathic hypereosinophilia is clonal disorder? clonality identified by targeted sequencing","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.anai.2018.05.014_bib0028","doi-asserted-by":"crossref","first-page":"40588","DOI":"10.18632\/oncotarget.5845","article-title":"Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome","volume":"6","author":"Andersen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.anai.2018.05.014_bib0029","first-page":"317","article-title":"Clonal hematopoiesis of indeterminate potential","volume":"113","author":"Heuser","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.anai.2018.05.014_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.24.021605.090720","article-title":"The eosinophil","volume":"24","author":"Rothenberg","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0032","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-97-1-78","article-title":"The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations","volume":"97","author":"Fauci","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0033","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","article-title":"Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia","volume":"109","author":"Jovanovic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.anai.2018.05.014_bib0034","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.rmed.2010.09.011","article-title":"Lung involvement in hypereosinophilic syndromes","volume":"105","author":"Dulohery","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0036","first-page":"282","article-title":"Case report: the first report of idiopathic hypereosinophilic syndrome involved with lung and middle ear","volume":"309","author":"Takayama","year":"1995","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.anai.2018.05.014_bib0037","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jaci.2015.03.004","article-title":"Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease","volume":"135","author":"Martin","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0038","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cgh.2009.03.022","article-title":"A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis","volume":"7","author":"Protheroe","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2018.05.014_bib0039","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1465-9921-12-116","article-title":"Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury","volume":"12","author":"Willetts","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.anai.2018.05.014_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1103005","article-title":"Eosinophil granule protein localization in eosinophilic endomyocardial disease","volume":"365","author":"Wright","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0041","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0042","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2018.05.014_bib0043","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2012.07.055","article-title":"Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes","volume":"131","author":"Roufosse","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.05.014_bib0044","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clml.2012.09.018","article-title":"Long-term follow-up of patients with hypereosinophilic syndrome treated with alemtuzumab, an anti-CD52 antibody","volume":"13","author":"Strati","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.anai.2018.05.014_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaip.2015.01.013","article-title":"Biologic therapies targeting eosinophils: current status and future prospects","volume":"3","author":"Legrand","year":"2015","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618303806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618303806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:20:09Z","timestamp":1761052809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618303806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1081120618303806"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.05.014","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}